|
9th ANNUAL AFRICAN AMERICAN PROSTATE CANCER DISPARITY SUMMIT
|
|
PHEN's Ninth Annual African American Prostate Cancer Disparity Summit will be hosted on Thursday and Friday, September 19th and 20th in Washington D.C.
Registration deadline is August 28th
|
|
STAND UP TO CANCER (SU2C)
PROSTATE CANCER DREAM TEAM
|
|
A Treatment Opportunity for Black Men
|
|
A unique opportunity for Black prostate cancer patients to receive treatment with a drug approved by the FDA to increase survival and to participate in a groundbreaking project that will help define the future approach for treating prostate cancer.
|
|
PROSTATE CANCER SURVIVOR NETWORK ... Please Join
|
|
Prostate cancer survivors play a crucial role in the fight against Prostate Cancer by mobilizing
their loved ones, churches and communities. Survivors and their families are encouraged to join the Survivor Network
|
|
Support PHEN's efforts in the Fight Against Prostate Cancer
|
|
 |
|
MANAGING PROSTATE CANCER SURVIVORSHIP
|
|
WEBCAST: August 14 at 6 pm ET
|
 | | Philip J. Saylor, MD |
PHEN's August webcast will present "Managing Prostate Cancer Survivorship."
All Prostate Cancer survivors and their family members will benefit from this informative session.
The Guest Speaker
Philip J. Saylor, MD, Medical Oncologist at Massachusetts General Hospital (Boston, MA), is a specialist who has written numerous articles on managing prostate cancer survivorship. He will share his expertise and findings with the webcast viewers, who will be able to submit questions via email, Facebook and Twitter.
Please join us for this webcast on Wednesday, August 14th, at 6 pm. The webcast link will be available on PHEN's website: www.rapcancer.org.
|
|
COMING: September 11th Webcast
|
|
 Prostate Cancer and Sex:
The Rarely Discussed Facts
The Guest Speaker
Nelson E. Benett, MD, Senior Staff Physician, Lahey Institute of Oncology, and Assistant Professor of Urology, Tufts University
|
|
PHEN THANKS ITS NATIONAL SPONSORS
Accuray, Inc.
Amgen, Inc.
Astellas / Medivation, Inc.
Bayer Healthcare
BN ImmunoTherapeutics, Inc.
Dana-Farber Cancer Institute
Dendreon Corporation
Genentech, Inc.
Janssen Biotech, Inc.
Millenium Pharmaceuticals, Inc. / The Takeda Oncology Company
|
|
|
